Position in CRSP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,544,498
+$494,454 QoQ
Shares Held
64,989
+1.4% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 521 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 96%
None 4%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. CRSP ranks #96 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in CRSP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,544,498 | 64,989 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,050,044 | 64,117 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $3,188,141 | 60,796 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $4,233,840 | 65,327 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,241,756 | 66,648 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $951,375 | 27,957 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,329,973 | 33,790 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,493,023 | 31,780 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,776,928 | 32,900 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,151,674 | 31,568 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,204,118 | 51,184 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,178,621 | 136,123 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $7,526,238 | 134,062 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,209,306 | 137,283 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,083,849 | 125,064 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,243,703 | 126,147 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,745,620 | 127,458 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,414,577 | 118,123 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $6,948,645 | 91,695 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,795,868 | 96,452 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $20,757,534 | 128,220 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $14,351,734 | 117,782 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $46,751,525 | 305,346 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $11,871,359 | 141,934 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $13,559,786 | 184,512 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $8,070,919 | 190,307 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||